|

Fezolinetant Clinical Trials

2 actively recruiting trials across 2 locations

No change since May 2026

Also known as: ESN364;, VEOZAH™

Pipeline

Phase 2: 2

Top Sponsors

  • Yale University1
  • University of Vermont1

Indications

  • Cancer2
  • Prostate CA1
  • Androgen Deprivation Therapy1
  • Breast Cancer Early Stage Breast Cancer (Stage 1-3)1
  • Breast Cancer1

New Haven, Connecticut1 trial

FLASH-Breast: Evaluating the Efficacy of Fezolinetant in Reducing Vasomotor Symptoms in Women With Breast Cancer on Endocrine Therapy

Yale University

Phase 2

Burlington, Vermont1 trial

Fezolinetant for Treating Hot Flashes in Men With Prostate Cancer

University of Vermont Medical Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.